SCHEMBL7583434

SCHEMBL7583434

Cc1ccccc1-c1cc(=O)c2cc(O)ccc2o1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.70
CYP3A4 P08684 5/20 0.70
CYP2C19 P33261 3/20 0.70
ALDH1A1 P00352 2/20 0.70
TSHR P16473 2/20 0.70
MAPT P10636 5/20 0.65
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
CALM1 P0DP23 1/20 0.65
PKM P14618 1/20 0.65
FTO Q9C0B1 1/20 0.65
CSNK2A2 P19784 4/20 0.62
CSNK2B P67870 4/20 0.62
CSNK2A1 P68400 4/20 0.62
ATM Q13315 1/20 0.60
TP53 P04637 4/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
ALOX15 P16050 2/20 0.60
LMNA P02545 1/20 0.60
THRB P10828 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30143812 0.85 HPGD (0.78) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL1058712 0.85 HPGD (0.78) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL27806529 0.83 HPGD (0.67) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL3205778 0.83 HPGD (0.67) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL31675843 0.82 CYP3A4 (1.00) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL4626639 0.82 CYP3A4 (1.00) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL718119 0.80 HPGD (0.74) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL28003485 0.80 HPGD (0.62) HPGDCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL11638456 0.79 AR (0.56) HPGDCYP3A4CYP2C19ALDH1A1TSHR
6-Hydroxyflavone SCHEMBL29628861 0.79 MAPT (1.00) HPGDCYP3A4CYP2C19ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070059-B1 CHROMANONE AND THIOCHROMANONE DERIVATIVES NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6346626-B1 DRUGS FOR TREATMENT OF SKIN DISORDERS SUCH AS ACNE, SEBORRHEA, ANDROGENIC ALOPECIA AND HIRSUTISM, OR IN THE TOPICAL TREATMENT OF SQUAMOUS CELL CARCINOMA NOVARTIS AG (CH) 2002-02-12 US disclosed